Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface

Launched by CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL (CHUM) · Dec 12, 2019

Keywords

ClinConnect Summary

This clinical trial is studying the "lacrimal fingerprint," which is a way to analyze the tear fluid in people with certain eye conditions. The goal is to understand how tears differ in common eye problems like Dry Eye Syndrome, Infectious Keratoconjunctivitis, Mucous Membrane Pemphigoid, and Allergic Conjunctivitis. By collecting and analyzing this information, researchers hope to create a standard reference that can help improve diagnosis and treatment for these conditions.

To be eligible for this trial, participants should be adults aged 18 and older who either have one of the mentioned eye conditions or have healthy corneas. Unfortunately, younger individuals and those unable to give informed consent are not eligible to participate. If you join the study, you can expect to provide samples of your tears for analysis. This research is important as it may lead to better understanding and management of eye diseases, ultimately improving care for patients like you.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * Patients with healthy corneas or suffering from one of these pathologies:
• • Dry eye syndrome; Infectious keratitis and/or conjunctivitis; Mucous membrane pemphigoid; Allergic conjunctivitis.
• Exclusion Criteria:
• • Patients younger than 18 years old;
• • Patients incapable of giving informed consent.